ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag business nonprofit biotech drug development

The Profits of Nonprofit
Megan Scudellari | Jan 1, 2011 | 7 min read
The surprising results when drug development and altruism collide
The Profits of Nonprofit
Megan Scudellari | Jan 1, 2011 | 7 min read
By Megan Scudellari The Profits of Nonprofit The surprising results when drug development and altruism collide Victoria Hale, founder of the Institute of OneWorld Health, the first nonprofit pharmaceutical company in the US POPTECH In the beginning, they called her a fool. When pharmaceutical chemist Victoria Hale told friends and colleagues that she wanted to start a nonprofit pharma company, they laughed at her, said it was career suicide, that it could
Female Frontrunners
Jef Akst | Feb 1, 2012 | 7 min read
How to successfully surmount the challenges women face in becoming biotech industry leaders
2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
Minding the Drug Development Gap
Edward Spack | Nov 6, 2005 | 6 min read
Twenty-five years after the enactment of the Bayh-Dole Act, scientists and administrators in academia who are interested in moving bench discoveries to the clinic are learning what travelers in London's subway system already know: It's important to "mind the gap."
When the Line Between Science and Business Blurs
Ted Agres(tagres@the-scientist.com) | Feb 27, 2005 | 6 min read
In 2004, media reports and US congressional investigations revealed that dozens of intramural scientists and officials at the National Institutes of Heath had received substantial amounts of cash and stock options by consulting with drug and biotech companies, many of which had dealings with the agency.
Start It Up
Dan Cossins | Apr 1, 2013 | 8 min read
Young researchers who left the academic path to transform their bright ideas into thriving companies discuss their experiences, and how you can launch your own business.
Venture Capital, with a Twist
Ted Agres(tagres@the-scientist.com) | Jul 17, 2005 | 5 min read
Jamie Heywood, chief executive of the Amyotrophic Lateral Sclerosis Therapy Development Foundation (ALSTDF), founded the nonprofit biotech company in 1999 after his brother was diagnosed with ALS.
High-Priced Biotech Drugs: Are They Worth It?
Susan Warner(swarner@the-scientist.com) | Dec 5, 2004 | 6 min read
4,000 for a course of treatment.
Feldbaum to Biotech Leaders: Cooperate and Share
Paula Park | Jul 7, 2002 | 4 min read
Photo: Courtesy of Carl Feldbaum Carl Feldbaum Financiers and biotechnology business leaders suspended their networking for a few minutes at the BIO 2002 annual convention in Toronto as Carl Feldbaum, chairman of the powerful US Biotechnology Industry Organization, urged them to cooperate with their competitors and assist the poor. Feldbaum's 10-point Biotechnology Foreign Policy,1 introduced over a sumptuous lunch, would provide appropriate and affordable vaccines and drugs for developi

Run a Search

ADVERTISEMENT